The best-performing stocks in today's US healthcare sector are all deeply involved in AI-driven drug development.



It might be catalyzed by Moderna's Science Day yesterday—the CEO emphasized using AI to drastically shorten R&D cycles and significantly reduce trial-and-error costs, with data to back it up.

Bookmark the stocks below; their breakout might not take five years.
View Original
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned